Search

Search Constraints

You searched for: Author/Creator Barata, Pedro C.

Search Results

4. Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA. Issue 10 (8th March 2018)

5. Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer. (2020)

6. Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma. Issue 1 (29th January 2018)

7. Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer. (11th November 2019)

8. Differential responses to taxanes and PARP inhibitors in ATM‐ versus BRCA2‐mutated metastatic castrate‐resistant prostate cancer. Issue 3 (16th November 2022)

9. Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. Issue 6 (9th December 2021)

10. Improving attribution of adverse events in oncology clinical trials. (June 2019)